![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Eleven Generic Companies Must Face Class-Action Pricing Lawsuit
Eleven Generic Companies Must Face Class-Action Pricing Lawsuit
A Pennsylvania federal court ruled that 11 generic manufacturers, including several subsidiaries of Teva Pharmaceuticals, must answer to a class-action lawsuit claiming they violated state consumer protection and unfair trade practice laws by inflating their prices.
Brought by a plumbers’ union health insurance plan, the lawsuit named a multitude of defendants, including several Actavis companies — all Teva subsidiaries — as well as Apotex and Dr. Reddy’s.
Fifteen companies moved to dismiss the case on the grounds the court lacked jurisdiction.
Upcoming Events
-
21Oct